Oxygen-Free Days as an Outcome Measure in Clinical Trials of Therapies for COVID-19 and Other Causes of New-Onset Hypoxemia

Fourth Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV-4) Host Tissue Investigators

Research output: Contribution to journalReview articlepeer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Oxygen-Free Days as an Outcome Measure in Clinical Trials of Therapies for COVID-19 and Other Causes of New-Onset Hypoxemia'. Together they form a unique fingerprint.

Medicine & Life Sciences